Roll-On Deodorant / Antiperspirant

Applicable Standard: KS EAS 960:2020 (KEBS) — Deodorants and Antiperspirants — Specification

Roll-on deodorant and antiperspirant were among the eleven new East African cosmetic standards KEBS adopted to open regional market access, and KS EAS 960:2020 draws a sharper line than most importers expect between the two product types — a “deodorant” that masks odor and reduces bacterial activity, and an “antiperspirant” that actively blocks perspiration through aluminum-salt actives — even when both are sold in an identical roll-on format. The two are tested and labeled differently, and a surprising number of shipments are flagged simply because the product is formulated as one and labeled, or marketed, as the other. Roll-on is also the format where compliance issues are most containable — aerosol antiperspirants carry an additional layer of flammable-propellant regulation that roll-on avoids entirely, which is one reason importers new to this category are steered toward roll-on and stick formats first, and why a shipment that unexpectedly includes an aerosol SKU alongside roll-on units under one paperwork submission is treated as a materially different risk profile rather than a minor format variation.

Why This Category Gets Flagged

The most common issue is an undeclared or unverified antiperspirant active concentration. Aluminum chlorohydrate and aluminum-zirconium complexes are the functional actives in antiperspirants, and their concentration is a directly testable parameter rather than simply an ingredient-list entry — a product claiming “24-hour protection from sweat” without a verified active concentration on file is treated as an unsubstantiated antiperspirant claim, not a harmless marketing phrase. The second issue is pH outside the range appropriate for underarm application: underarm skin is thinner and more frequently micro-abraded through shaving than most other body-application sites, so KS EAS 960:2020 sets a narrower acceptable pH band than general cosmetics carry, and formulations optimized for a different regional market sometimes fall outside it without anyone re-validating the pH locally. Third, alcohol content and container labeling mismatches occur when a consignment mixes roll-on and aerosol SKUs under one paperwork submission and the aerosol-appropriate flammability labeling ends up on the roll-on units, or vice versa — a documentation-shipment mismatch rather than a product defect, but one that still triggers a hold. Fourth, aluminum-salt actives are mildly corrosive to certain metal components over an extended shelf life, and roll-on applicator balls or caps made from an incompatible metal alloy can corrode or discolor well before the product’s declared expiry date — a packaging-compatibility issue that shows up as a quality complaint at retail rather than at the border, but one KEBS increasingly asks about as part of stability documentation for antiperspirant-specific formulations.

Test Parameters

The parameters below reflect the split KS EAS 960:2020 is built around — a deodorant is assessed primarily on antimicrobial and odor performance, while an antiperspirant carries the additional active-concentration and efficacy-substantiation burden that its function-changing claim requires.

Labeling Requirements

The label must clearly designate the product as either “deodorant” or “antiperspirant”, matching the actual formulation rather than defaulting to whichever term tests better with consumers, plus a full INCI ingredient list, net content, batch code, manufacture and expiry dates, usage directions, warnings against use on broken or irritated skin, and country of origin, in English and/or Kiswahili. Duration claims — “24-hour”, “48-hour” — require efficacy substantiation on file even though the specific number is rarely re-tested at the border. Where a single product line is sold in both roll-on and aerosol formats, each format’s packaging should carry labeling appropriate to its own hazard and use profile rather than a single label design applied across both without adjustment.

Packaging & Documentation

A Certificate of Conformity is issued following KEBS conformity assessment, with the route applied — document review, document review plus sampling, or full physical inspection — determined by a risk assessment carried out on receipt of the request. A consignment mixing roll-on and aerosol SKUs, or one making an unverified duration claim, is a common trigger for escalation to the more intensive inspection route rather than clearing on document review.

Typical Gaps We Find

Mismatched deodorant/antiperspirant labeling against the actual active-ingredient formulation is the most common defect we see, usually the result of a single label template being reused across a product line with different underlying formulations. Unverified duration claims are the second most common, particularly on private-label products where the “24-hour” language was copied from a competitor’s packaging rather than derived from the manufacturer’s own testing. pH drift on formulations reformulated for a different regional market without re-validating against KS EAS 960:2020’s underarm-specific band rounds out the list — again, a documentation and validation gap rather than evidence the product itself is unsafe. Each of these is a formulation-documentation or packaging-validation gap rather than a sign the product itself is unsafe, which is exactly the kind of finding a pre-shipment review is meant to surface while it still costs a label correction rather than a returned consignment.